NewsRepurposed Drug Shows Promise for Treating Cardiac Arrhythmiasby University of ChicagoResearchers use new tool to isolate five previously unknown CaMKII inhibitors
Product NewsAnti-evolocumab Antibodies for Use in Preclinical and Clinical Drug Developmentby Bio-Rad LaboratoriesThese recombinant antibodies are suitable for developing pharmacokinetic and anti-drug antibody assays
InsightsBiotechnology: Bringing New Treatments to Marketby Rachel MuenzA snapshot of research and tools focused on early drug discovery that could eventually bring more effective treatments to patients
NewsFDA Approves Genetically Modified Salmon For Human Consumptionby U.S. Food and Drug AdministrationIn addition, the FDA found that approving the GE salmon would not have a significant environmental impact
ArticleNon-GMP in a GMP World: Does it Really Exist?by Dan ZuccarelloSpecific strategies, when implemented, can permit “not for GMP” activities to co-exist within a GMP world
App NoteEmploying Virtual Patients to Advance Drug Developmentby Ellen LeinfussComputer modeling and simulation has become a vital part of the drug development process
NewsUsing the Human Genome to Repurpose Medicine for Zika Virusby Florida Atlantic UniversityProfessor identifies 55 drug targets for the Zika virus from the human genome, leading to the identification of 79 FDA-approved drugs currently being used to treat other conditions
Product FocusNew Techniques in MS-Based Proteomic Screeningby Brandoch Cook, PhDHow these novel methods can lead to revolutions in drug discovery and target identification
NewsUS Cancer Drug Costs Increasing, Despite Competitionby Ben-Gurion University of the NegevAnticancer drug costs in the United States increase substantially after launch regardless of competition, according to a new study
InsightsChallenges and Solutions for Validating HCP ELISAsby CytivaValidating host cell protein ELISAs is an essential part of biologics development